{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T12:40:10Z","timestamp":1748781610759,"version":"3.41.0"},"reference-count":126,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:p>Arguably, one of the most important milestones in Huntington disease research since the discovery of the gene responsible has been the generation of different genetic animal models. Although clinical reports have shown evidence of progressive cognitive impairments in gene carriers before motor symptoms are diagnosed, such symptoms have been much less obvious in animal models. In this review, we summarize the three main classes of animal models for Huntington disease and describe some relevant translational assays for behavioural deficits evaluation. Finally, we argue that a good knowledge of the emergence of motor and cognitive symptoms in mice and rat models is indispensable for the selection of endpoint measures in early preclinical drug screening studies.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000217","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T22:42:54Z","timestamp":1455748974000},"page":"403-414","source":"Crossref","is-referenced-by-count":5,"title":["Of rodents and men: understanding the emergence of motor and cognitive symptoms in Huntington disease"],"prefix":"10.1097","volume":"27","author":[{"given":"Yah-Se K.","family":"Abada","sequence":"first","affiliation":[{"name":"Brain and Spine Institute (ICM), Team \u2018Alzheimer\u2019s and Prion Diseases\u2019, CNRS-UMR 7225 Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart A.","family":"Ellenbroek","sequence":"additional","affiliation":[{"name":"School of Psychology, Victoria University of Wellington, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2012.10.039","article-title":"Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington\u2019s disease","volume":"238","author":"Abada","year":"2013a","journal-title":"Behav Brain Res"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"e68584","DOI":"10.1371\/journal.pone.0068584","article-title":"Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease","volume":"8","author":"Abada","year":"2013b","journal-title":"PLoS One"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"e71633","DOI":"10.1371\/journal.pone.0071633","article-title":"Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease","volume":"8","author":"Abada","year":"2013c","journal-title":"PLoS One"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/npp.2011.308","article-title":"Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder","volume":"37","author":"Ahmari","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-0003-2-20","article-title":"Gait dynamics in mouse models of Parkinson\u2019s disease and Huntington\u2019s disease","volume":"2","author":"Amende","year":"2005","journal-title":"J Neuroeng Rehabil"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11517-012-0863-2","article-title":"Statistical characteristics of finger-tapping data in Huntington\u2019s disease","volume":"50","author":"Antoniades","year":"2012","journal-title":"Med Biol Eng Comput"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","article-title":"Medial frontal cortex mediates perceptual attentional set shifting in the rat","volume":"20","author":"Birrell","year":"2000","journal-title":"J Neurosci"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1037\/0735-7044.117.6.1233","article-title":"Exploratory activity and fear conditioning abnormalities develop early in R6\/2 Huntington\u2019s disease transgenic mice","volume":"117","author":"Bolivar","year":"2003","journal-title":"Behav Neurosci"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainresbull.2010.05.004","article-title":"Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington\u2019s disease knock-in mice","volume":"88","author":"Brooks","year":"2012a","journal-title":"Brain Res Bull"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","article-title":"Selective cognitive impairment in the YAC128 Huntington\u2019s disease mouse","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res Bull"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat","volume":"70","author":"Brouillet","year":"1998","journal-title":"J Neurochem"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J Neurosci"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1423-0127-17-9","article-title":"Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"17","author":"Chuang","year":"2010","journal-title":"J Biomed Sci"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington\u2019s disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol Neurodegener"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nlm.2009.06.002","article-title":"Progressive imbalance in the interaction between spatial and procedural memory systems in the R6\/2 mouse model of Huntington\u2019s disease","volume":"92","author":"Ciamei","year":"2009","journal-title":"Neurobiol Learn Mem"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/cddis.2012.121","article-title":"An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity","volume":"3","author":"Cisbani","year":"2012","journal-title":"Cell Death Dis"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neuron.2008.03.001","article-title":"Behavioral phenotyping strategies for mutant mice","volume":"57","author":"Crawley","year":"2008","journal-title":"Neuron"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington\u2019s disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00415-005-0929-2","article-title":"Role of hypokinesia and bradykinesia in gait disturbances in Huntington\u2019s disease: a biomechanical study","volume":"253","author":"Delval","year":"2006","journal-title":"J Neurol"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneumeth.2007.04.009","article-title":"The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection","volume":"164","author":"Deumens","year":"2007","journal-title":"J Neurosci Methods"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/380069a0","article-title":"Dissociation in prefrontal cortex of affective and attentional shifts","volume":"380","author":"Dias","year":"1996","journal-title":"Nature"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bph.12164","article-title":"Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington\u2019s disease","volume":"169","author":"Doria","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"R34-20230914","article-title":"Clinical assessment of the effect of tetrabenazine on functional scales in huntington disease: a pilot open label study","volume":"2","author":"Fekete","year":"2012","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterization","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"issue":"Pt 7","key":"R37-20230914","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/awt132","article-title":"Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mousemodel of Huntington\u2019s disease","volume":"136","author":"Fisher","year":"2013","journal-title":"Brain"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fncel.2014.00295","article-title":"Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington\u2019s disease","volume":"8","author":"Francelle","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2006.06.002","article-title":"Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice","volume":"173","author":"Garner","year":"2006","journal-title":"Behav Brain Res"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/mds.870100412","article-title":"Reliance on advance information and movement sequencing in Huntington\u2019s disease","volume":"10","author":"Georgiou","year":"1995","journal-title":"Mov Disord"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","article-title":"Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington\u2019s disease","volume":"20","author":"Giralt","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mds.22003","article-title":"Falls and gait disturbances in Huntington\u2019s disease","volume":"23","author":"Grimbergen","year":"2008","journal-title":"Mov Disord"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/08977150150502613","article-title":"Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries","volume":"18","author":"Hamers","year":"2001","journal-title":"J Neurotrauma"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/neu.1994.11.187","article-title":"The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury","volume":"11","author":"Hamm","year":"1994","journal-title":"J Neurotrauma"},{"key":"R46-20230914","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington\u2019s disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"R47-20230914","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"R48-20230914","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2007.04.001","article-title":"Gait parameters of treadmill versus overground locomotion in mouse","volume":"181","author":"Herbin","year":"2007","journal-title":"Behav Brain Res"},{"key":"R49-20230914","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R50-20230914","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(99)01604-2","article-title":"Spatio-temporal analysis of light-induced Fos expression in the retina of rd mutant mice","volume":"834","author":"Huerta","year":"1999","journal-title":"Brain Res"},{"key":"R51-20230914","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"R52-20230914","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease","volume":"57","year":"2001","journal-title":"Neurology"},{"key":"R54-20230914","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"R55-20230914","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","article-title":"Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons","volume":"21","author":"Jackson","year":"1998","journal-title":"Neuron"},{"key":"R56-20230914","doi-asserted-by":"crossref","first-page":"e105662","DOI":"10.1371\/journal.pone.0105662","article-title":"Reduced motivation in the BACHD rat model of Huntington disease is dependent on the choice of food deprivation strategy","volume":"9","author":"Jansson","year":"2014","journal-title":"PLoS One"},{"key":"R57-20230914","first-page":"169","article-title":"The paradigm of Huntington disease","volume":"45","author":"Jenkins","year":"1989","journal-title":"Am J Hum Genet"},{"key":"R58-20230914","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1093\/hmg\/dds379","article-title":"Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington\u2019s disease mice: implications for the ubiquitin-proteasomal and autophagy systems","volume":"21","author":"Jia","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R59-20230914","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpsychires.2012.11.018","article-title":"Prepulse inhibition in psychiatric disorders--apart from schizophrenia","volume":"47","author":"Kohl","year":"2013","journal-title":"J Psychiatr Res"},{"key":"R60-20230914","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1212\/WNL.35.10.1450","article-title":"The gait abnormality of Huntington\u2019s disease","volume":"35","author":"Koller","year":"1985","journal-title":"Neurology"},{"key":"R61-20230914","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"R62-20230914","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biocel.2010.10.014","article-title":"Huntington\u2019s disease: from molecular basis to therapeutic advances","volume":"43","author":"Krobitsch","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"R63-20230914","article-title":"Increased body weight of the BAC HD transgenic mouse model of huntington\u2019s disease accounts for some but not all of the observed HD-like motor deficits","volume":"5","author":"Kudwa","year":"2013","journal-title":"PLoS Curr"},{"key":"R64-20230914","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/jnnp.58.5.598","article-title":"Comparison of executive and visuospatial memory function in Huntington\u2019s disease and dementia of Alzheimer type matched for degree of dementia","volume":"58","author":"Lange","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 5","key":"R65-20230914","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington\u2019s disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"issue":"Pt 7","key":"R66-20230914","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","article-title":"Evidence for specific cognitive deficits in preclinical Huntington\u2019s disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"key":"R67-20230914","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0028-3932(99)00035-4","article-title":"Discrimination, reversal, and shift learning in Huntington\u2019s disease: mechanisms of impaired response selection","volume":"37","author":"Lawrence","year":"1999","journal-title":"Neuropsychologia"},{"issue":"Pt 7","key":"R130-20230914","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/brain\/123.7.1349","article-title":"Visual object and visuospatial cognition in Huntington\u2019s disease: implications for information processing in corticostriatal circuits","volume":"123","author":"Lawrence","year":"2000","journal-title":"Brain"},{"key":"R68-20230914","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jgg.2012.05.002","article-title":"Influence of species differences on the neuropathology of transgenic Huntington\u2019s disease animal models","volume":"39","author":"Li","year":"2012","journal-title":"J Genet Genomics"},{"key":"R69-20230914","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R70-20230914","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J Neurosci"},{"key":"R71-20230914","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"R72-20230914","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/jnnp.41.9.809","article-title":"Platelet monoamine oxidase activity in Huntington\u2019s chorea","volume":"41","author":"Mann","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R73-20230914","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington\u2019s disease for translation to the clinic: best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov Disord"},{"key":"R74-20230914","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol Dis"},{"key":"R75-20230914","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"R76-20230914","doi-asserted-by":"crossref","first-page":"e99520","DOI":"10.1371\/journal.pone.0099520","article-title":"Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6\/2 and zQ175 mouse models of Huntington\u2019s disease","volume":"9","author":"Menalled","year":"2014","journal-title":"PLoS One"},{"key":"R77-20230914","first-page":"CD006456","article-title":"Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease","author":"Mestre","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R78-20230914","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1155\/2013\/408362","article-title":"The role of dopamine and glutamate modulation in Huntington disease","volume":"26","author":"Mittal","year":"2013","journal-title":"Behav Neurol"},{"key":"R79-20230914","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01262","article-title":"Initial sequencing and comparative analysis of the mouse genome","volume":"420","author":"Waterston","year":"2002","journal-title":"Nature"},{"journal-title":"NINDS Clinical Trials","article-title":"Announcement of 2CARE Early study Closure","year":"2014","key":"R80-20230914"},{"key":"R81-20230914","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","article-title":"Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington\u2019s disease","volume":"15","author":"Nguyen","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R82-20230914","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2004.07.011","article-title":"Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington\u2019s disease transgenic mice","volume":"17","author":"Norflus","year":"2004","journal-title":"Neurobiol Dis"},{"key":"R83-20230914","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","article-title":"Huntington\u2019s disease Clinical Review","volume":"340","author":"Novak","year":"2010","journal-title":"BMJ"},{"key":"R84-20230914","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4522(00)00020-8","article-title":"Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies","volume":"97","author":"Ouary","year":"2000","journal-title":"Neuroscience"},{"key":"R85-20230914","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainresbull.2008.10.007","article-title":"The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington\u2019s disease are task- and protocol-dependent: influence of non-motor factors on locomotor function","volume":"78","author":"Pallier","year":"2009","journal-title":"Brain Res Bull"},{"key":"R86-20230914","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R87-20230914","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbr.2006.04.027","article-title":"A comparison analysis of hindlimb kinematics during overground and treadmill locomotion in rats","volume":"172","author":"Pereira","year":"2006","journal-title":"Behav Brain Res"},{"key":"R88-20230914","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/2013\/705373","article-title":"The pathophysiology and pharmacological treatment of Huntington disease","volume":"26","author":"Pidgeon","year":"2013","journal-title":"Behav Neurol"},{"key":"R89-20230914","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jns.2014.06.035","article-title":"Alpha-theta border EEG abnormalities in preclinical Huntington\u2019s disease","volume":"344","author":"Ponomareva","year":"2014","journal-title":"J Neurol Sci"},{"key":"R90-20230914","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R91-20230914","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington\u2019s disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J"},{"key":"R92-20230914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2008.12.005","article-title":"Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington\u2019s disease","volume":"34","author":"Ramaswamy","year":"2009","journal-title":"Neurobiol Dis"},{"key":"R93-20230914","first-page":"862","article-title":"Coordination of fingertip forces during precision grip in premanifest Huntington\u2019s disease","volume":"26","author":"Rao","year":"2011"},{"key":"R94-20230914","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneumeth.2014.06.013","article-title":"Comparison of automated home-cage monitoring systems: emphasis on feeding behaviour, activity and spatial learning following pharmacological interventions","volume":"234","author":"Robinson","year":"2014","journal-title":"J Neurosci Methods"},{"key":"R95-20230914","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington\u2019s disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp Neurol"},{"key":"R96-20230914","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R97-20230914","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington\u2019s disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci Lett"},{"key":"R98-20230914","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease","volume":"90","author":"Schwarcz","year":"2010","journal-title":"Prog Neurobiol"},{"key":"R99-20230914","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/11208330-000000000-00000","article-title":"Tetrabenazine: for chorea associated with Huntington\u2019s disease","volume":"25","author":"Scott","year":"2011","journal-title":"CNS Drugs"},{"key":"R100-20230914","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington\u2019s disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R101-20230914","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R102-20230914","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/35000576","article-title":"Motor disorder in Huntington\u2019s disease begins as a dysfunction in error feedback control","volume":"403","author":"Smith","year":"2000","journal-title":"Nature"},{"key":"R103-20230914","first-page":"616","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington\u2019s disease mice","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochem Biophys Acta"},{"key":"R104-20230914","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J Neurosci"},{"key":"R105-20230914","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J Comp Neurol"},{"key":"R106-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"R107-20230914","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/exnr.2002.7947","article-title":"The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington\u2019s disease","volume":"176","author":"Sun","year":"2002","journal-title":"Exp Neurol"},{"key":"R108-20230914","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","article-title":"Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia","volume":"24","author":"Swerdlow","year":"1998","journal-title":"Schizophr Bull"},{"key":"R109-20230914","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","article-title":"Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington\u2019s disease","volume":"58","author":"Swerdlow","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R110-20230914","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R111-20230914","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1073\/pnas.88.6.2065","article-title":"FVB\/N: an inbred mouse strain preferable for transgenic analyses","volume":"88","author":"Taketo","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"R112-20230914","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Tang","year":"2007","journal-title":"J Neurosci"},{"key":"R113-20230914","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"R114-20230914","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneumeth.2014.06.017","article-title":"Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington\u2019s disease","volume":"234","author":"Urbach","year":"2014","journal-title":"J Neurosci Methods"},{"key":"R132-20230914","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"van Raamsdonk","year":"2005","journal-title":"J Neurosci"},{"key":"R115-20230914","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2202-11-92","article-title":"Automated quantitative gait analysis in animal models of movement disorders","volume":"11","author":"Vandeputte","year":"2010","journal-title":"BMC Neurosci"},{"key":"R116-20230914","doi-asserted-by":"crossref","first-page":"682712","DOI":"10.1155\/2012\/682712","article-title":"Lessons learned from the transgenic Huntington\u2019s disease rats","volume":"2012","author":"Vlamings","year":"2012","journal-title":"Neural Plast"},{"key":"R117-20230914","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington\u2019s disease","volume":"12","author":"von H\u00f6rsten","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R118-20230914","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"R119-20230914","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"R120-20230914","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R121-20230914","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res Bull"},{"key":"R122-20230914","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.physbeh.2008.10.020","article-title":"Age, experience and genetic background influence treadmill walking in mice","volume":"96","author":"Wooley","year":"2009","journal-title":"Physiol Behav"},{"key":"R124-20230914","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nbt0997-859","article-title":"Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome","volume":"15","author":"Yang","year":"1997","journal-title":"Nat Biotechnol"},{"key":"R125-20230914","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington\u2019s disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"R126-20230914","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","article-title":"A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease","volume":"32","author":"Yu-Taeger","year":"2012","journal-title":"J Neurosci"},{"key":"R127-20230914","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbr.2011.09.041","article-title":"Motor and non-motor behaviour in experimental Huntington\u2019s disease","volume":"226","author":"Zeef","year":"2012a","journal-title":"Behav Brain Res"},{"key":"R128-20230914","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbr.2011.11.009","article-title":"Memory deficits in the transgenic rat model of Huntington\u2019s disease","volume":"227","author":"Zeef","year":"2012b","journal-title":"Behav Brain Res"},{"key":"R129-20230914","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201608000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T12:13:57Z","timestamp":1748780037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201608000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":126,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000217","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}